amylin glp-1 dual agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Can amylin-based drugs upstage GLP-1

10.1097/GME.0000000000000640 20

The most common concomitant glucose-lowering medications were metformin (84%) and basal insulin (23%)

The Look AHEAD: Action for Health in Diabetes (NCT00017953) clinical trial randomized 5145 overweight or obese persons 4576 years of age with T2DM to intensive lifestyle intervention to achieve and maintain weight loss through reduced caloric intake and increased physical activity (intervention) or diabetes support and education (control) [24]

Chart of the Day: Medicare, Medicaid, and Insurers Replaced High Costs With More Hurdles, LDI Expert Finds Chart of the Day: Mark Cubans Cost Plus Drugs Can Save Employer-Covered Patients Hundreds on Some Generics Will Implementation Create Sweeping Losses or a Return to Balance and Self-Sufficiency

Stay well-hydrated